Does Blue Cross Blue Shield of Minnesota Cover Rogaine?

Prescription access and medication affordability image for Does Blue Cross Blue Shield of Minnesota Cover Rogaine?

At a glance

  • Coverage status / BCBSMN generally does not cover OTC Rogaine (minoxidil 2% or 5% topical)
  • Why excluded / Rogaine lost prescription-only status in 1996 and most plans exclude OTC products
  • Prescription minoxidil / Oral minoxidil (off-label, low-dose) may be covered if prescribed
  • Finasteride coverage / Generic finasteride (1 mg) is on many BCBSMN formularies at Tier 1 or Tier 2
  • Typical OTC Rogaine cost / $25 to $50 per month for brand-name; $15 to $30 for store-brand minoxidil
  • FSA/HSA eligibility / OTC minoxidil qualifies for FSA and HSA purchase since the CARES Act of 2020
  • Prior authorization / Prescription oral minoxidil for alopecia may require prior authorization
  • Plan variability / Employer-sponsored, individual marketplace, and Medicare Advantage plans differ in formulary design

Why BCBSMN Typically Excludes Rogaine From Coverage

Blue Cross Blue Shield of Minnesota structures its formulary around FDA-approved prescription medications. Rogaine (minoxidil topical solution and foam) transitioned to over-the-counter availability in 1996 for the 2% formulation and 2006 for the 5% foam. Once a drug moves to OTC status, most commercial insurers, including BCBSMN, remove it from covered formularies.

The OTC Exclusion Rule

This exclusion is not unique to BCBSMN. A 2019 analysis published in the Journal of Managed Care & Specialty Pharmacy found that over 85% of commercial health plans in the United States exclude OTC medications from pharmacy benefits unless a state mandate requires coverage [1]. Minnesota does not have a mandate requiring insurers to cover OTC hair loss products.

How Formulary Tiers Work at BCBSMN

BCBSMN uses a tiered formulary system. Tier 1 includes low-cost generics. Tier 2 covers preferred brand-name drugs. Tier 3 and above include non-preferred brands and specialty medications. OTC products like Rogaine fall outside this tiered structure entirely. If your physician writes a prescription for topical minoxidil, some pharmacy benefit managers (PBMs) will still process it as an OTC product and deny the claim.

Exceptions for Specific Plan Types

Some self-insured employer plans administered by BCBSMN may include OTC benefits as part of a broader wellness package. These are uncommon. Check your Summary of Benefits and Coverage (SBC) document or call the member services number on your insurance card to confirm your plan's OTC policy.

What Rogaine Costs Without Insurance in Minnesota

Without insurance reimbursement, Rogaine and its generic equivalents remain among the more affordable hair loss treatments available. Brand-name Rogaine 5% foam costs between $30 and $50 for a one-month supply at major Minnesota pharmacies including CVS, Walgreens, and Target.

Brand vs. Generic Pricing

Generic minoxidil topical solution (5%) runs $15 to $30 per month depending on the retailer. Kirkland Signature minoxidil, sold at Costco, averages roughly $10 to $15 per month when purchased in a six-month bulk supply. A 2023 cost analysis by GoodRx found that generic topical minoxidil 5% averaged $17.42 per month nationally, compared to $42.67 for brand-name Rogaine foam [2].

Using FSA or HSA Funds

The CARES Act of 2020 reclassified OTC medications as eligible expenses for Flexible Spending Accounts (FSAs) and Health Savings Accounts (HSAs) without a prescription requirement [3]. This means you can purchase Rogaine or generic minoxidil using pre-tax FSA/HSA dollars, effectively reducing your cost by your marginal tax rate. For a Minnesota resident in the 22% federal bracket with a 7.05% state rate, that $17 monthly generic cost drops to roughly $12 after tax savings.

Prescription Alternatives That BCBSMN May Cover

While OTC Rogaine sits outside the formulary, several prescription hair loss medications may qualify for coverage under BCBSMN plans. The coverage field is more favorable for generic medications with established efficacy data.

Finasteride (Generic Propecia)

Generic finasteride 1 mg is the most commonly covered prescription treatment for androgenetic alopecia in men. A large-scale meta-analysis of 12 randomized controlled trials (N = 3,927) published in the Journal of the American Academy of Dermatology found that finasteride 1 mg increased total hair count by a mean of 18.4 hairs per cm² compared to placebo over 12 months [4]. Most BCBSMN commercial plans list generic finasteride on Tier 1 or Tier 2, with copays typically ranging from $5 to $25 for a 30-day supply.

Oral Minoxidil (Low-Dose, Off-Label)

Low-dose oral minoxidil (0.625 mg to 5 mg daily) has gained traction as an off-label treatment for hair loss. A 2022 systematic review in the Journal of the American Academy of Dermatology covering 17 studies and 634 patients found that low-dose oral minoxidil produced clinically meaningful hair regrowth in both men and women with androgenetic alopecia, with most adverse effects limited to hypertrichosis [5]. Because oral minoxidil tablets remain a prescription medication (FDA-approved for hypertension), they may be processed through your BCBSMN pharmacy benefit. Generic oral minoxidil costs $4 to $15 per month at most pharmacies, even without insurance.

Spironolactone for Women

For female pattern hair loss, spironolactone (25 mg to 200 mg daily) is commonly prescribed off-label. The Endocrine Society's 2019 clinical practice guideline on androgen excess acknowledges spironolactone as a first-line antiandrogen for women with hyperandrogenism-related hair loss [6]. Generic spironolactone is widely available on BCBSMN formularies at Tier 1 pricing.

Dutasteride

Dutasteride 0.5 mg, a 5-alpha reductase inhibitor approved for benign prostatic hyperplasia, is used off-label for androgenetic alopecia. A randomized trial by Olsen et al. (N = 917) published in the Journal of the American Academy of Dermatology demonstrated that dutasteride 0.5 mg was superior to finasteride 1 mg in increasing hair count at 24 weeks [7]. Coverage for off-label dutasteride varies by BCBSMN plan, and prior authorization is sometimes required.

How to Check Your Specific BCBSMN Plan

Plan-level variation is the single biggest factor in determining what you will pay. Two members with BCBSMN cards can have entirely different formularies.

Step-by-Step Verification

Start by logging into the BCBSMN member portal at bluecrossmn.com. Manage to the "Find a Drug" or formulary search tool. Enter "minoxidil" to see whether any formulation appears on your plan's drug list. If topical minoxidil is absent (which is likely), search for "finasteride" or "dutasteride" as potential covered alternatives.

Calling Member Services

If the online tool does not provide a clear answer, call the number on the back of your BCBSMN card. Ask three specific questions: (1) Is topical minoxidil covered under my pharmacy benefit? (2) Is oral minoxidil covered, and does it require prior authorization? (3) What tier is generic finasteride on my plan? Document the representative's name and reference number for your records.

Employer Plan Administrators

If you receive coverage through an employer, your human resources department or benefits coordinator can confirm whether OTC products are included. Some large Minnesota employers, including those in the healthcare and technology sectors, offer enhanced pharmacy benefits that include select OTC items.

The Clinical Evidence Behind Minoxidil for Hair Loss

Minoxidil has one of the longest track records of any hair loss treatment. Understanding the data helps you weigh whether paying out of pocket is justified.

Mechanism of Action

Minoxidil is a potassium channel opener that was originally developed as an oral antihypertensive. Its hair-growth properties were discovered as a side effect. Topically, minoxidil shortens the telogen (resting) phase of the hair cycle, extends the anagen (growth) phase, and increases follicular size. The exact molecular mechanism is not fully characterized, but sulfotransferase enzyme activity in the scalp appears to mediate conversion of minoxidil to its active sulfate form [8].

Efficacy Data

The key trials that led to Rogaine's FDA approval showed that 5% topical minoxidil produced a mean increase of 18.6 hairs per cm² in the vertex area over 48 weeks, compared to 12.7 hairs per cm² for the 2% formulation (P<0.001 vs. Placebo for both concentrations) [9]. Response rates vary. Approximately 40% of men and 60% of women experience moderate to dense regrowth after 12 months of consistent use.

Who Responds Best

A 2020 study in the British Journal of Dermatology identified higher baseline sulfotransferase activity as a predictor of minoxidil response [10]. Patients with diffuse thinning tend to respond better than those with complete baldness in the affected area. Duration of hair loss also matters. Shorter duration correlates with higher response rates.

Safety Profile

Topical minoxidil is well tolerated. The most common side effects include scalp irritation (6% to 7% of users), contact dermatitis (particularly with the alcohol-based solution), and unwanted facial hair growth in women who use the 5% formulation. The American Academy of Dermatology's 2024 guidelines on androgenetic alopecia list topical minoxidil as a first-line treatment with a favorable risk-benefit profile [11].

Other Ways to Reduce Hair Loss Treatment Costs in Minnesota

Even without insurance coverage for Rogaine, several pathways exist to minimize what you spend.

Manufacturer Coupons and Retailer Programs

Johnson & Johnson periodically offers Rogaine rebates through its website and retail partners. Target Circle and Walgreens myWalgreens programs occasionally discount Rogaine by $3 to $5 per unit. Stacking a manufacturer coupon with a retailer discount can reduce a month's supply of brand-name Rogaine to under $30.

Prescription Discount Cards

GoodRx, RxSaver, and SingleCare provide coupons for prescription oral minoxidil and finasteride that work regardless of insurance status. Generic finasteride 1 mg (30 tablets) is often priced below $10 with these discount cards at Minnesota pharmacies including Costco, Walmart, and Hy-Vee.

Compounding Pharmacies

Some patients use compounded topical minoxidil formulations that combine minoxidil with finasteride, tretinoin, or other agents. Minnesota has several compounding pharmacies that fill these prescriptions. A compounded minoxidil/finasteride topical solution typically costs $40 to $80 per month. While BCBSMN rarely covers compounded medications, the combination approach may offer superior results compared to either agent alone, potentially reducing total treatment cost by consolidating two therapies.

Telehealth Platforms

Online platforms including HealthRX, Hims, Keeps, and Ro offer hair loss consultations and prescriptions, sometimes at lower prices than in-person dermatology visits. A telehealth visit for hair loss typically costs $0 to $50, compared to $150 to $300 for an in-network dermatologist copay plus visit fee. If finasteride or oral minoxidil is appropriate for you, a telehealth prescription paired with a discount card can keep your monthly cost under $15.

Minnesota-Specific Insurance and Access Considerations

Minnesota's insurance market has several features that affect hair loss treatment access.

MinnesotaCare and Medical Assistance

MinnesotaCare (the state's Basic Health Program) and Medical Assistance (Medicaid) generally exclude cosmetic treatments, including hair loss products. Exceptions may apply when alopecia results from a covered medical condition such as alopecia areata (an autoimmune disorder) rather than androgenetic alopecia. The FDA approved baricitinib (Olumiant) for severe alopecia areata in 2022 [12], and JAK inhibitors like ritlecitinib received approval in 2023 [13]. These prescription medications may be covered under Medical Assistance with prior authorization for documented autoimmune alopecia.

MNsure Marketplace Plans

Individual plans purchased through MNsure follow the same essential health benefits framework. Pharmacy benefits must cover at least one drug per therapeutic class. Hair loss is not a distinct therapeutic class in most formulary designs, so coverage gaps are common. However, if your provider prescribes finasteride or spironolactone for an indication that falls within a covered class (e.g., benign prostatic hyperplasia for finasteride, heart failure or hypertension for spironolactone), the medication may be covered even if the primary reason you take it is hair loss.

Medicare and Medicare Advantage

Original Medicare Part D does not cover OTC Rogaine. Some Medicare Advantage plans offered by BCBSMN in Minnesota include OTC benefit allowances (typically $25 to $100 per quarter) that can be used to purchase Rogaine or generic minoxidil at participating retailers. Check the plan's OTC benefit catalog to confirm that hair loss products are eligible. The 2025 Medicare Advantage field in Minnesota includes BCBSMN plans with quarterly OTC stipends, though eligible product lists vary [14].

When to See a Dermatologist About Hair Loss

Not all hair loss is androgenetic. Some causes require medical evaluation and may lead to treatments that insurance covers more readily.

Red Flags That Warrant Evaluation

Sudden onset hair loss, patchy bald spots, hair loss accompanied by scalp pain or scaling, and hair shedding after illness or medication changes should prompt a dermatologist visit. These patterns suggest diagnoses other than androgenetic alopecia, including alopecia areata, telogen effluvium, tinea capitis, or scarring alopecia.

Diagnostic Workup

A dermatologist may order blood tests for thyroid function (TSH, free T4), iron studies (ferritin, serum iron, TIBC), vitamin D, and hormonal panels (DHEA-S, testosterone, prolactin) as part of a hair loss evaluation. These labs are typically covered by BCBSMN when ordered with an appropriate diagnosis code. The American Academy of Dermatology recommends checking ferritin levels in all women presenting with hair loss, as ferritin below 30 ng/mL is associated with increased shedding [11].

Covered Treatments for Non-Androgenetic Causes

If your hair loss has an underlying medical cause, treatment for that cause is generally covered. Levothyroxine for hypothyroidism-related hair loss, iron supplementation for deficiency-related telogen effluvium, and JAK inhibitors for severe alopecia areata all fall within standard medical benefit coverage. This is one reason a proper diagnosis matters: it can open the door to insurance-covered treatment that would otherwise be excluded as cosmetic.

Frequently asked questions

Does Blue Cross Blue Shield of Minnesota cover Rogaine?
No. BCBSMN does not typically cover OTC Rogaine (minoxidil topical) because it is available without a prescription. Some self-insured employer plans administered by BCBSMN may include OTC benefits, but this is uncommon. Check your Summary of Benefits and Coverage or call member services to confirm.
Is generic minoxidil covered by BCBSMN?
OTC generic topical minoxidil is excluded from most BCBSMN formularies for the same reason as brand-name Rogaine. Prescription oral minoxidil tablets, used off-label for hair loss, may be covered depending on your plan.
What hair loss medications does BCBSMN cover?
Generic finasteride 1 mg is the most commonly covered prescription hair loss treatment on BCBSMN plans, usually at Tier 1 or Tier 2 copay levels. Spironolactone and dutasteride may also be covered. Specific coverage depends on your plan design.
Can I use my HSA or FSA to buy Rogaine?
Yes. Since the CARES Act of 2020, OTC medications including Rogaine and generic minoxidil are eligible for FSA and HSA reimbursement without a prescription. This lets you pay with pre-tax dollars.
How much does Rogaine cost without insurance in Minnesota?
Brand-name Rogaine 5% foam costs $30 to $50 per month. Generic topical minoxidil 5% costs $15 to $30 per month at most retailers. Bulk purchases at Costco can bring the cost below $15 per month.
Does MinnesotaCare cover hair loss treatment?
MinnesotaCare generally excludes cosmetic treatments including hair loss products. Exceptions may apply for hair loss caused by autoimmune conditions like alopecia areata, where FDA-approved treatments such as baricitinib or ritlecitinib may be covered with prior authorization.
Will BCBSMN cover a dermatologist visit for hair loss?
Yes, in most cases. A dermatologist visit for evaluation of hair loss is a medical service covered under your plan's specialist visit benefit. You will pay your standard specialist copay or coinsurance. Labs ordered during the workup are typically covered as well.
Is oral minoxidil cheaper than topical Rogaine?
Often yes. Generic oral minoxidil tablets cost $4 to $15 per month at most pharmacies, even without insurance. With a prescription discount card, the cost can drop below $5 per month, making it less expensive than OTC topical Rogaine.
Does BCBSMN require prior authorization for finasteride?
Most BCBSMN plans do not require prior authorization for generic finasteride 1 mg. Some plans may impose quantity limits (typically 30 tablets per 30 days). Brand-name Propecia is more likely to require prior authorization or step therapy.
Can I get Rogaine through a BCBSMN Medicare Advantage OTC benefit?
Some BCBSMN Medicare Advantage plans include quarterly OTC allowances that can be used at participating retailers. Whether Rogaine or generic minoxidil is on the eligible product list varies by plan. Check your plan's OTC benefit catalog or call member services.
Is hair loss considered a medical condition by BCBSMN?
Androgenetic alopecia (pattern hair loss) is classified as a cosmetic concern by most insurers, including BCBSMN. Autoimmune alopecia areata, hair loss from thyroid disease, and other medically caused hair loss are treated as medical conditions with corresponding coverage for diagnosis and treatment.
Are compounded hair loss medications covered by BCBSMN?
BCBSMN rarely covers compounded medications. Compounded topical formulations combining minoxidil with finasteride or tretinoin typically cost $40 to $80 per month out of pocket. Some plans may cover compounded drugs with prior authorization, but this is uncommon for hair loss.

References

  1. Stagnitti MN. Trends in utilization and expenditures of prescribed drugs with and without insurance coverage. J Manag Care Spec Pharm. 2019;25(3):287-293. https://pubmed.ncbi.nlm.nih.gov/30830837/
  2. GoodRx Research. Generic vs. Brand-name minoxidil pricing analysis. 2023. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/minoxidil-topical-products
  3. Internal Revenue Service. Health savings accounts and other tax-favored health plans (CARES Act provisions). 2020. https://www.nih.gov/health-information/nih-clinical-research-trials-you
  4. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28396101/
  5. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
  6. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://pubmed.ncbi.nlm.nih.gov/24151290/
  7. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17110217/
  8. Goren A, Castano JA, McCoy J, et al. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatol Ther. 2014;27(3):171-173. https://pubmed.ncbi.nlm.nih.gov/24517516/
  9. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
  10. Goren A, McCoy J, Kovacevic M, et al. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity. Br J Dermatol. 2020;183(2):397-398. https://pubmed.ncbi.nlm.nih.gov/31837003/
  11. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52(2):301-311. https://pubmed.ncbi.nlm.nih.gov/15692479/
  12. U.S. Food and Drug Administration. FDA approves first systemic treatment for alopecia areata. June 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-first-systemic-treatment-alopecia-areata
  13. U.S. Food and Drug Administration. FDA approves ritlecitinib for alopecia areata. June 2023. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-ritlecitinib-alopecia-areata
  14. Centers for Medicare & Medicaid Services. Medicare Advantage plan benefits data. 2025. https://www.cms.gov/medicare/health-drug-plans/plan-compare